Stirling Products Limited
Stirling Products Limited is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Latest Media Releases
17/06/2011 10:52:00
Healthcare group, Stirling Products Limited (ASX:STI) is pleased to advise that the Company’s new KidneyVital™ product, to be launched to the Australian national pharmacy market by its …
15/06/2011 10:01:00
Healthcare group, Stirling Products Limited (ASX:STI) is pleased to advise:
High Density Aerosol (HDA) License Agreement
The Company and its joint venture partner, Zodiac Capital Limited ha…
Latest News
Company News /
by -
13 years ago
11 Jan 2011 - Healthcare group Stirling Products Ltd (ASX:STI) receives the green light to establish a pharmaceutical plant in Canada.
Interviews /
by -
13 years ago
28 Sep 2010 - Stirling Products Limited (ASX:STI) Managing Director, Peter Boonen, Sales & Marketing Director, Neil Covey, and Stirling Drug Delivery Device Project Leader, Ross Ha…
Interviews /
by -
13 years ago
29 July– Stirling Products (ASX:STI), MD, Peter Boonen discusses progress with sales, re-licensing its Canadian pharmaceutical plant and its potential acquisition of TeleMedCare Ho…
Interviews /
by -
14 years ago
9 March – Stirling Products, MD, Peter Boonen discusses the appointment of Professor Glyn Tonge to the Board, its Canadian plant, and its products.
